Description: LexaGene Holdings Inc. is a biotechnology company focused on providing instrumentation that performs automated pathogen detection. These easy-to-use instruments are designed to be used by facility personnel with no specialized molecular biology training. The company anticipates marketing its technology into the food safety, veterinary diagnostics, water quality monitoring, and aquaculture pathogen surveillance markets. LexaGene is listed as a Tier 2 company on the TSX Venture Exchange.
Home Page: www.lexagene.com
500 Cummings Center
Beverly,
MA
01915
United States
Phone:
800 215 1824
Officers
| Name | Title |
|---|---|
| Dr. John F. Regan | Founder, Chairman & CEO |
| Mr. Jeffrey Mitchell | CFO, Treasurer & Corp. Sec. |
| Mr. Steven Armstrong | Chief Operating Officer |
| Mr. Allan John Fabbro | VP of Corp. Devel. |
| Nicole Ridgedale | Director of Corp. Marketing |
| Mr. Jay Adelaar | VP of Capital Markets |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 7.0495 |
| Price-to-Sales TTM: | 130.0696 |
| IPO Date: | |
| Fiscal Year End: | February |
| Full Time Employees: | 33 |